| Primary |
| Growth Of Eyelashes |
52.0% |
| Product Used For Unknown Indication |
23.7% |
| Dry Eye |
4.8% |
| Supplementation Therapy |
3.9% |
| Hypertension |
3.0% |
| Hypothyroidism |
1.9% |
| Hormone Replacement Therapy |
1.6% |
| Blood Cholesterol Increased |
1.2% |
| Depression |
1.1% |
| Eye Lubrication Therapy |
1.0% |
| Hypersensitivity |
0.9% |
| Gastrooesophageal Reflux Disease |
0.8% |
| Hypotrichosis |
0.7% |
| Thyroid Disorder |
0.5% |
| Anxiety |
0.5% |
| Asthma |
0.5% |
| Contraception |
0.5% |
| Diabetes Mellitus |
0.5% |
| Hair Growth Abnormal |
0.5% |
| Blood Pressure |
0.4% |
|
| Wrong Technique In Drug Usage Process |
28.3% |
| Madarosis |
10.9% |
| Drug Ineffective |
9.1% |
| Trichorrhexis |
8.9% |
| Ocular Hyperaemia |
8.4% |
| Eyelids Pruritus |
3.9% |
| Therapeutic Response Decreased |
3.7% |
| Scleral Hyperaemia |
3.2% |
| Skin Discolouration |
3.2% |
| Inappropriate Schedule Of Drug Administration |
2.9% |
| Vision Blurred |
2.9% |
| Skin Hyperpigmentation |
2.4% |
| Erythema Of Eyelid |
1.9% |
| Incorrect Dose Administered |
1.9% |
| Eyelid Oedema |
1.8% |
| Blepharal Pigmentation |
1.5% |
| Eye Irritation |
1.4% |
| Pruritus |
1.4% |
| Eye Pruritus |
1.1% |
| Eye Swelling |
1.1% |
|
| Secondary |
| Growth Of Eyelashes |
43.9% |
| Product Used For Unknown Indication |
19.0% |
| Dry Eye |
6.8% |
| Supplementation Therapy |
4.2% |
| Hormone Replacement Therapy |
3.4% |
| Hypertension |
3.4% |
| Eye Lubrication Therapy |
2.5% |
| Hypothyroidism |
2.5% |
| Hair Growth Abnormal |
2.1% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Neuralgia |
1.7% |
| Anxiety |
1.3% |
| Hypotrichosis |
1.3% |
| Thyroid Disorder |
1.3% |
| Alopecia |
0.8% |
| Blood Cholesterol Increased |
0.8% |
| Blood Pressure |
0.8% |
| Blood Pressure Fluctuation |
0.8% |
| Contact Lens Therapy |
0.8% |
| Contraception |
0.8% |
|
| Wrong Technique In Drug Usage Process |
38.3% |
| Therapeutic Response Decreased |
9.3% |
| Trichorrhexis |
8.4% |
| Madarosis |
7.5% |
| Drug Ineffective |
4.7% |
| Inappropriate Schedule Of Drug Administration |
4.7% |
| Scleral Hyperaemia |
4.7% |
| Erythema Of Eyelid |
2.8% |
| Skin Discolouration |
2.8% |
| Trichiasis |
2.8% |
| Vision Blurred |
2.8% |
| Therapeutic Response Unexpected |
1.9% |
| Therapy Cessation |
1.9% |
| Visual Acuity Reduced |
1.9% |
| Acne |
0.9% |
| Blepharospasm |
0.9% |
| Expired Drug Administered |
0.9% |
| Eyelid Margin Crusting |
0.9% |
| Eyelids Pruritus |
0.9% |
| Foreign Body Sensation In Eyes |
0.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.0% |
| Skin Wrinkling |
25.0% |
| Growth Of Eyelashes |
10.0% |
| Acne |
5.0% |
| Antiallergic Therapy |
5.0% |
| Arthropod Bite |
5.0% |
| Dry Eye |
5.0% |
| Eye Lubrication Therapy |
5.0% |
| Herpes Virus Infection |
5.0% |
| Hormone Replacement Therapy |
5.0% |
|
| Inappropriate Schedule Of Drug Administration |
25.0% |
| Incorrect Dose Administered |
25.0% |
| Injection Site Swelling |
25.0% |
| Wrong Technique In Drug Usage Process |
25.0% |
|
